Other News

GBT Commences Research on an External Device for Arterial Clogs and Tissue Imaging Based on its Proprietary Radio Technology

SAN DIEGO, May 04, 2021 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”) is researching an external device for arterial and tissue imaging based on its proprietary radio technology, combined with the company’s robotic research. The research contemplates an external unit targeted to be operated with a […]

High risk heart patients underuse hospice care options

National Partnership for Healthcare and Hospice Partnership in collaboration with the American Heart Association are working to improve quality and access to hospice and palliative/advanced illness care May 03, 2021 15:02 ET | Source: National Partnership for Healthcare and Hospice Innovation Dallas and Washington, D.C., May 03, 2021 (GLOBE NEWSWIRE) — Despite […]

Prevencio and Seattle Children’s Research Institute Present Highly Accurate Data for First Time Artificial Intelligence-driven Multiple Protein Blood Test for Kawasaki Disease

Kawasaki Disease—a critical childhood disease—linked to COVID-19 KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces presentation of highly accurate data on an Artificial Intelligence (AI)-driven blood test for Kawasaki disease (KD) at the Pediatric Academic Societies (PAS) International Sessions. The novel test, HART KD, was jointly developed with Seattle Children’s Research Institute and […]

Journal of Medical Economics Article Demonstrates Economic Benefits of Cardiovascular Systems Orbital Atherectomy in the Treatment of Peripheral Artery Disease (PAD)

Lower cumulative procedure costs at one- and two-years when orbital atherectomy used ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that a new article published in the Journal of […]

FineHeart Breaks New Ground With Successful Removal of the ICOMS FLOWMAKER® in a 90-day In-vivo Trial

Towards a new standard for device indication: Implantation for temporary or permanent use Easy removal with a beating heart without damage to the myocardium 30 days after implantation Normal heart functioning 60 days after explantation Completely sealed operation with dedicated implant fixation system Quick recovery and short hospital stay Autonomy […]

Confluent Medical Announces Strategic Investment in The Electrospinning Company

Confluent Medical Invests in The Electrospinning Company to Expand Design Options Utilized in Structural Heart Markets SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Confluent Medical Technologies Inc. (Confluent) announced today a strategic investment in The Electrospinning Company Ltd. (Electrospinning). Electrospinning, a UK-based company, has developed a proprietary electrospinning process which will expand the design options […]

Medtronic Announces CE Mark of Evolut™ PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe

As TAVI Patient Population Grows, PRO+ TAVI System Launches with Four Valve Sizes and Lowest Delivery Profile DUBLIN, May 3, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark of the Evolut™ PRO+ TAVI System – the newest-generation Medtronic TAVI system that builds off […]

New members elected to Occlutech Board of Directors

Medical device company Occlutech Holding AG, one of the world´s leading providers of minimally invasive structural heart disease devices, announces the election of four new members to the board SCHAFFHAUSEN, Switzerland, May 3, 2021 /PRNewswire/ — Occlutech Holding AG (“Occlutech”) today announces that Marianne Dicander Alexandersson, Mette-Marie Harild, Helena Levander, and Michel Lussier have been elected as […]